Krystal Biotech (KRYS) Stock
Krystal Biotech (KRYS) closed at $298.55 on Nov 17, 2026; its Tenet Score is 66 of 100 against 340 Healthcare peers.
5 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $298.55
- Nov 17, 2026
- Market cap
- $8.8B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 40.8×
- TTM through Sep 30, 2026 · as of close, Nov 16, 2026
- 52-week range
- 198.02 – 382.54
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 66/100
- Solid · 340 Healthcare peers
Industry: Drugs
Krystal Biotech Inc scores 66/100. Solid. Strongest on financial health and quality, value is the soft spot, trading at 41× earnings versus 340 Healthcare peers. Insufficient inputs: Tenet 66 is built from 3 of 4 pillars, from 85% of its inputs. Growth is left out because no growth rate could be measured.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✓ Buffett Quality
- ~ Piotroski F-Score
- ~ Munger Compounders
- ✕ Magic Formula
- ✕ Graham Defensive
- ✕ Quality Compounder
13F flows & insider trades land here.
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical st…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Repligen Corp.RGEN | 49 | $10.4B |
| Madrigal Pharmaceuticals IncMDGL | 32 | $9.8B |
| TG Therapeutics IncTGTX | 43 | $9.6B |
| Spyre Therapeutics Inc.SYRE | 43 | $9.4B |
| Praxis Precision Medicines IncPRAX | 46 | $8.7B |
| Protagonist Therapeutics IncPTGX | 65 | $8.1B |
| Alkermes plcALKS | 37 | $7.8B |
| Corcept Therapeutics IncCORT | 54 | $7.6B |
| Rhythm Pharmaceuticals Inc.RYTM | 36 | $7.5B |
| Cytokinetics IncCYTK | 34 | $7.4B |
Common questions
What sector and industry is Krystal Biotech in?
Krystal Biotech is in the Healthcare sector and the Drugs industry.
What is Krystal Biotech's Tenet Score?
Krystal Biotech's Tenet Score is 66 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




